mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |